Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.7600 (-1.54%) ($5.3000 - $6.0000) on Mon. Apr. 8, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.2% (three month average) | RSI | 55 | Latest Price | $5.7600(-1.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.2% a day on average for past five trading days. | Weekly Trend | CAPR advances 3.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) VXX(86%) PCY(12%) XBI(11%) EWY(10%) LIT(10%) | Factors Impacting CAPR price | CAPR will decline at least -3.1% in a week (0% probabilities). URA(-20%) XLE(-16%) XOP(-15%) USO(-15%) BLOK(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.1% (StdDev 6.2%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
5 Day Moving Average | $5.99(-3.84%) | 10 Day Moving Average | $5.74(0.35%) | 20 Day Moving Average | $5.57(3.41%) | To recent high | -15.3% | To recent low | 15.2% | Market Cap | $113m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |